checkAd
    Startseite > Aktien > Viridian Therapeutics > Nachrichten
    Viridian Therapeutics Aktie
    11,200
     
    EUR
    0,00 %
    0,000 EUR
    Letzter Kurs 27.05.24 Tradegate
    10,900
     
    EUR
    400 STK
    Geldkurs 19:44:31
    11,100
     
    EUR
    400 STK
    Briefkurs 19:44:31
    ISIN: US92790C1045 · WKN: A2QMUH · SYM: 1S1 · USA

    Neueste Nachrichten

    Viridian Therapeutics to Participate in Upcoming May Investor Conferences
    10.05.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
    08.05.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    03.05.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
    29.04.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    04.04.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    06.03.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
    05.03.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
    27.02.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer
    16.02.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    06.02.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
    18.01.24 · Business Wire (engl.) · Viridian Therapeutics
    Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
    17.01.24 · Business Wire (engl.) · Viridian Therapeutics